These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


171 related items for PubMed ID: 38750218

  • 1. Dynamin-related protein 1 mediates the therapeutic effect of isoliquiritigenin in diabetic intimal hyperplasia via regulation of mitochondrial fission.
    Zhang BF, Wu ZH, Chen K, Jin HJ, Wu J, Huang ZY, Lu XW, Zheng XT.
    Hypertens Res; 2024 Jul; 47(7):1908-1924. PubMed ID: 38750218
    [Abstract] [Full Text] [Related]

  • 2. Decreasing mitochondrial fission diminishes vascular smooth muscle cell migration and ameliorates intimal hyperplasia.
    Wang L, Yu T, Lee H, O'Brien DK, Sesaki H, Yoon Y.
    Cardiovasc Res; 2015 May 01; 106(2):272-83. PubMed ID: 25587046
    [Abstract] [Full Text] [Related]

  • 3. Mdivi-1, a mitochondrial fission inhibitor, reduces angiotensin-II- induced hypertension by mediating VSMC phenotypic switch.
    Deng Y, Li S, Chen Z, Wang W, Geng B, Cai J.
    Biomed Pharmacother; 2021 Aug 01; 140():111689. PubMed ID: 34004510
    [Abstract] [Full Text] [Related]

  • 4. Targeting mitochondrial fission as a potential therapeutic for abdominal aortic aneurysm.
    Cooper HA, Cicalese S, Preston KJ, Kawai T, Okuno K, Choi ET, Kasahara S, Uchida HA, Otaka N, Scalia R, Rizzo V, Eguchi S.
    Cardiovasc Res; 2021 Feb 22; 117(3):971-982. PubMed ID: 32384150
    [Abstract] [Full Text] [Related]

  • 5. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission.
    Lu ZY, Qi J, Yang B, Cao HL, Wang RY, Wang X, Chi RF, Guo CL, Yang ZM, Liu HM, Li B.
    Cardiovasc Drugs Ther; 2020 Oct 22; 34(5):605-618. PubMed ID: 32564303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Isoliquiritigenin attenuates glutamate-induced mitochondrial fission via calcineurin-mediated Drp1 dephosphorylation in HT22 hippocampal neuron cells.
    Lee DG, Min JS, Lee HS, Lee DS.
    Neurotoxicology; 2018 Sep 22; 68():133-141. PubMed ID: 30048666
    [Abstract] [Full Text] [Related]

  • 9. Novel Drp1 GTPase Inhibitor, Drpitor1a: Efficacy in Pulmonary Hypertension.
    Wu D, Jansen-van Vuuren RD, Dasgupta A, Al-Qazazi R, Chen KH, Martin AY, Mewburn JD, Alizadeh E, Lima PDA, Jones O, Colpman P, Bentley RET, VandenBroek MM, Breault NM, Emon IM, Yerramilli VS, Jedlovčnik L, Zhao YY, Wells M, Sutendra G, Ormiston ML, Archer SL.
    Hypertension; 2024 Oct 22; 81(10):2189-2201. PubMed ID: 39162036
    [Abstract] [Full Text] [Related]

  • 10. PPARγ attenuates intimal hyperplasia by inhibiting TLR4-mediated inflammation in vascular smooth muscle cells.
    Zhang LL, Gao CY, Fang CQ, Wang YJ, Gao D, Yao GE, Xiang J, Wang JZ, Li JC.
    Cardiovasc Res; 2011 Dec 01; 92(3):484-93. PubMed ID: 21880694
    [Abstract] [Full Text] [Related]

  • 11. Salusin-β Promotes Vascular Smooth Muscle Cell Migration and Intimal Hyperplasia After Vascular Injury via ROS/NFκB/MMP-9 Pathway.
    Sun HJ, Zhao MX, Ren XS, Liu TY, Chen Q, Li YH, Kang YM, Wang JJ, Zhu GQ.
    Antioxid Redox Signal; 2016 Jun 20; 24(18):1045-57. PubMed ID: 26952533
    [Abstract] [Full Text] [Related]

  • 12. Dynamin-related protein 1-mediated mitochondrial mitotic fission permits hyperproliferation of vascular smooth muscle cells and offers a novel therapeutic target in pulmonary hypertension.
    Marsboom G, Toth PT, Ryan JJ, Hong Z, Wu X, Fang YH, Thenappan T, Piao L, Zhang HJ, Pogoriler J, Chen Y, Morrow E, Weir EK, Rehman J, Archer SL.
    Circ Res; 2012 May 25; 110(11):1484-97. PubMed ID: 22511751
    [Abstract] [Full Text] [Related]

  • 13. Dynamin-related protein inhibitor downregulates reactive oxygen species levels to indirectly suppress high glucose-induced hyperproliferation of vascular smooth muscle cells.
    Maimaitijiang A, Zhuang X, Jiang X, Li Y.
    Biochem Biophys Res Commun; 2016 Mar 18; 471(4):474-8. PubMed ID: 26903301
    [Abstract] [Full Text] [Related]

  • 14. Endogenous intermedin protects against intimal hyperplasia by inhibiting endoplasmic reticulum stress.
    Xue CD, Chen Y, Ren JL, Zhang LS, Liu X, Yu YR, Tang CS, Qi YF.
    Peptides; 2019 Nov 18; 121():170131. PubMed ID: 31408662
    [Abstract] [Full Text] [Related]

  • 15. The inhibition of the effect and mechanism of vascular intimal hyperplasia in Tiam1 knockout mice.
    Kou W, Xu X, Ji S, Chen M, Liu D, Wang K, Zhuang J, Yu Q, Zhao Q, Xu Y, Zhang H, Peng W.
    Biochem Biophys Res Commun; 2018 Feb 26; 497(1):248-255. PubMed ID: 29432743
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Silencing of PCK1 mitigates the proliferation and migration of vascular smooth muscle cells and vascular intimal hyperplasia by suppressing STAT3/DRP1-mediated mitochondrial fission.
    Zhang L, Chen Y, Pan Q, Fang S, Zhang Z, Wang J, Yang Y, Yang D, Sun X.
    Acta Biochim Biophys Sin (Shanghai); 2024 Sep 12. PubMed ID: 39262325
    [Abstract] [Full Text] [Related]

  • 18. Metformin Suppresses Diabetes-Accelerated Atherosclerosis via the Inhibition of Drp1-Mediated Mitochondrial Fission.
    Wang Q, Zhang M, Torres G, Wu S, Ouyang C, Xie Z, Zou MH.
    Diabetes; 2017 Jan 12; 66(1):193-205. PubMed ID: 27737949
    [Abstract] [Full Text] [Related]

  • 19. Isoliquiritigenin Reduces LPS-Induced Inflammation by Preventing Mitochondrial Fission in BV-2 Microglial Cells.
    Lee DG, Nam BR, Huh JW, Lee DS.
    Inflammation; 2021 Apr 12; 44(2):714-724. PubMed ID: 33150538
    [Abstract] [Full Text] [Related]

  • 20. Targeting HSP90 attenuates angiotensin II-induced adventitial remodelling via suppression of mitochondrial fission.
    Huang G, Cong Z, Wang X, Yuan Y, Xu R, Lu Z, Wang X, Qi J.
    Cardiovasc Res; 2020 Apr 01; 116(5):1071-1084. PubMed ID: 31346611
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.